💨 Abstract
The biotech company, Immunic, Inc., posted a second-quarter loss of $26.8 million, or 20 cents per share, missing analysts' estimates of a 18 cents per share loss.
Courtesy: WTOP Staff
Suggested
Netanyahu to seek approval for expanded Gaza military operations as 29 Palestinians are killed -
The diplomatic road that paved the way for a planned Trump-Putin meeting on Ukraine -
Abrams hits walk-off single and Nationals end 6-game skid with 2-1 win over Athletics -
July was Earth’s third-warmest on record, EU scientists say -
The number of Americans filing for jobless benefits rose modestly last week, but employers largely avoiding layoffs -
MDU Resources: Q2 Earnings Snapshot -
White Mountains: Q2 Earnings Snapshot -
Greystone Housing Impact: Q2 Earnings Snapshot -
Precision BioSciences: Q2 Earnings Snapshot -
Trump seeks to change how census collects data and wants to exclude immigrants in US illegally -